funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
United States
HQ address
6340 Quadrangle Drive, Chapel Hill, 27517, USA
Achelios Therapeutics is a pharmaceutical development company that focuses on advancing new product concepts through the 505(b)(2) process to early clinical proof of principle followed by asset (project) sale. Achelios has adopted a semi-virtual model to control costs and advance projects by utilizing its experienced team and on-call external pharmaceutical experts and partners. This allows the company’s management to precisely tailor project needs with the right level of expertise and/or key opinion leaders with influence at the FDA, academic medicine centers, and at the level of the payer (insurance company/government).

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats